stars 1 stars 2 stars 3

Colzyx is a regenerative biology company harnessing the power of collagen VI to help the body heal better. Built on more than 15 years of collagen VI research, our proprietary peptide technology is designed to activate and amplify natural mechanisms involved in tissue protection, repair and regeneration. WoundCom™, translates this biology into a clinically practical collagen matrix. WoundCom is our first path to human clinical validation — and an important proof point for a much broader technology platform. Beyond wound care, we see the potential to integrate Colzyx technology into existing and next-generation biomaterials across surgical reconstruction, implants, tissue engineering, dental, aesthetics and regenerative medicine. Our strategy is designed for scale: combining proprietary product development with licensing, OEM integration and strategic co-development to enable established partners to bring Colzyx biology into their own technologies and markets. One biology. Multiple applications. Working with the body’s biology to power the future of healing.

Colzyx Questions

The Colzyx annual revenue was $3 million in 2026.

Eskil Söderlind is the Chief Executive Officer and Co-Founder of Colzyx.

4 people are employed at Colzyx.

Colzyx is based in Lund, Skane.

The NAICS codes for Colzyx are [541714, 54, 5417, 54171, 541].

The SIC codes for Colzyx are [87, 873].

Top Colzyx Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users